Business Combinations (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Business Acquisitions by Acquisition, Consideration Transferred

The aggregate acquisition consideration was $173.4 million, consisting of (in thousands, except per share amounts):



Cash consideration	$	96,006
Total share consideration:
Actual number of shares issued	790
Multiplied by: Ligand closing share price on January 8, 2016	98
Total share consideration	$	77,373
Total consideration	$	173,379

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The acquisition consideration was allocated to the acquisition date fair values of acquired assets and assumed liabilities as follows (in thousands):



Cash and cash equivalents	$	3,504
Accounts receivable	5
Income tax receivable	136
Prepaid expenses and other current assets	1
Deferred tax liabilities, net	(55,708		)
Intangible asset with finite life - core technology	167,000
Liabilities assumed	(1,528		)
Goodwill	59,969
Total consideration	$	173,379

Schedule of Pro Forma Information

The following table presents supplemental pro forma information for the three and twelve months ended December 31, 2016 and December 31, 2015, as if the acquisition of OMT had occurred on January 1, 2015 (in thousands except for income per share):



	Three months ended					Twelve months ended
	December 31,					December 31,
	2016			2015		2016		2015
Revenue	$	38,185		$	24,571	$	111,449	$	80,365
Net (loss) income	$	(3,126	)	5,888		$	632	$	222,788

Basic (loss) income per share:	$	(0.15	)	$	0.30	$	0.03	$	11.26
Diluted (loss) income per share:	$	(0.15	)	$	0.27	$	0.03	$	10.50